Although Excretion‐EVs did not directly induce drug resistance in recipient bladder cancer cells, their selective enrichment in regulatory proteins, such as H3.2 (H3C14), LAMB1 and CD147, suggests an indirect role in maintaining chemoresistance. The gene discussed is LAMB1; the disease is urinary bladder carcinoma.